Moderna (MRNA) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Moderna (MRNA) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 2, 2023 (13:36)

Sector: Healthcare

The share price of Moderna, Inc. (MRNA) now

What analysts predict: $125.31
52-week High/Low: $217.25 / $62.55

50/200 Day Moving Average: $87.65 / $120.01

This figure corresponds to the Average Price over the previous 50/200 days. For Moderna stocks, the 50-day moving average is the resistance level today.

For Moderna stocks, the 200-day moving average is the resistance level today.

Are you interested in Moderna, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Moderna stock price in 2023, 2024, 2025, 2026, 2027. How much will one Moderna share be worth in 2023 - 2027?

When should I take profit in Moderna stock? When should I record a loss on Moderna stock? What are analysts' forecasts for Moderna stock? What is the future of Moderna stock? We forecast Moderna stock performance using neural networks based on historical data on Moderna stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Moderna stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Moderna shares. This happens once a day.




Historical and forecast chart of Moderna stock

The chart below shows the historical price of Moderna stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Moderna stock price can be found in the table below.

Long-term forecasts by years.

Moderna, Inc. is a biotech company based in Cambridge, Massachusetts that is engaged in drug discovery and RNA messenger drug development. The company is creating synthetic mRNA that can be injected into patients to help them create their own therapy.

Official site of the company

Moderna daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 04 84.13 82.19 85.10 3.55
Dec 05 85.46 83.66 86.29 3.15
Dec 06 83.51 82.49 84.21 2.09
Dec 07 80.97 79.95 82.87 3.65
Dec 08 81.11 80.12 82.08 2.44
Dec 09 80.17 78.38 81.80 4.37
Dec 10 79.89 77.88 80.90 3.88
Dec 11 80.43 79.81 81.83 2.54
Dec 12 80.26 79.39 81.27 2.37
Dec 13 81.35 79.25 82.15 3.66
Dec 14 81.35 80.24 82.23 2.48
Dec 15 80.18 78.08 81.62 4.53
Dec 16 80.72 79.76 82.84 3.86
Dec 17 80.77 78.57 82.39 4.86
Dec 18 81.82 79.84 84.03 5.24
Dec 19 82.22 80.70 84.18 4.32
Dec 20 82.88 81.93 84.91 3.65
Dec 21 84.62 83.32 86.55 3.87
Dec 22 83.02 81.48 85.17 4.53
Dec 23 80.73 79.01 82.71 4.69
Dec 24 79.68 79.01 80.99 2.51
Dec 25 80.24 78.87 81.65 3.53
Dec 26 80.21 78.02 80.77 3.53
Dec 27 81.31 79.26 82.62 4.24
Dec 28 83.33 81.43 85.02 4.41
Dec 29 81.87 80.12 83.19 3.83
Dec 30 82.44 80.48 83.68 3.98
Dec 31 80.08 79.32 81.34 2.54
Jan 01 81.48 79.68 82.96 4.12
Jan 02 82.25 80.20 82.88 3.34

Moderna Daily Price Targets


Moderna Stock Forecast 12-04-2023.

Forecast target price for 12-04-2023: $84.13.
Positive dynamics for Moderna shares will prevail with possible volatility of 3.425%.
Pessimistic target level: 82.19
Optimistic target level: 85.10

Moderna Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $85.46.
Positive dynamics for Moderna shares will prevail with possible volatility of 3.050%.
Pessimistic target level: 83.66
Optimistic target level: 86.29

Moderna Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $83.51.
Negative dynamics for Moderna shares will prevail with possible volatility of 2.048%.
Pessimistic target level: 82.49
Optimistic target level: 84.21

Moderna Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $80.97.
Negative dynamics for Moderna shares will prevail with possible volatility of 3.522%.
Pessimistic target level: 79.95
Optimistic target level: 82.87

Moderna Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $81.11.
Positive dynamics for Moderna shares will prevail with possible volatility of 2.387%.
Pessimistic target level: 80.12
Optimistic target level: 82.08

Moderna Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $80.17.
Negative dynamics for Moderna shares will prevail with possible volatility of 4.185%.
Pessimistic target level: 78.38
Optimistic target level: 81.80

MRNA (MRNA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 76.54 72.34 81.16 10.86

Moderna forecast for this year


Moderna Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $76.5413. Pessimistic: $72.34. Optimistic: $81.16



Moderna (MRNA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 75.30 71.37 76.66 6.90
Feb 77.67 72.22 82.57 12.53
Mar 70.75 68.33 72.92 6.29
Apr 69.73 66.53 74.50 10.70
May 75.57 73.46 77.54 5.26
Jun 78.29 74.20 82.94 10.53
Jul 81.25 75.62 83.96 9.93
Aug 82.49 81.01 85.46 5.21
Sep 85.83 79.89 88.31 9.54
Oct 88.15 86.57 91.96 5.87
Nov 91.17 89.36 96.17 7.08
Dec 94.94 90.93 99.56 8.67

Moderna (MRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 94.17 90.02 99.85 9.85
Feb 95.53 90.28 101.63 11.17
Mar 101.12 99.21 104.12 4.72
Apr 100.57 97.13 105.10 7.58
May 98.22 91.85 104.14 11.80
Jun 105.91 103.43 108.58 4.74
Jul 101.62 96.86 105.92 8.55
Aug 94.58 88.70 98.24 9.70
Sep 93.04 90.78 99.41 8.68
Oct 93.30 90.10 96.57 6.69
Nov 90.02 84.59 93.91 9.92
Dec 96.83 93.86 103.80 9.57

Moderna (MRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 99.27 93.82 103.29 9.17
Feb 104.90 102.91 111.88 8.02
Mar 106.97 103.51 110.15 6.03
Apr 106.49 102.27 109.08 6.24
May 101.51 95.48 106.62 10.45
Jun 96.94 94.32 99.56 5.26
Jul 100.60 93.99 103.59 9.26
Aug 99.97 93.31 102.31 8.79
Sep 103.39 96.69 108.23 10.66
Oct 111.02 106.92 117.31 8.86
Nov 110.02 105.86 117.74 10.09
Dec 114.18 106.68 118.19 9.74

Moderna (MRNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 120.14 115.60 126.84 8.86
Feb 124.90 118.94 132.99 10.56
Mar 120.06 114.98 126.22 8.90
Apr 110.99 103.29 114.18 9.54
May 115.38 107.49 117.87 8.81
Jun 119.64 113.50 124.81 9.06
Jul 122.98 119.10 130.17 8.50
Aug 123.42 118.42 129.08 8.26
Sep 124.86 116.55 131.27 11.22
Oct 127.56 118.83 130.66 9.05
Nov 124.23 118.75 130.16 8.76
Dec 126.13 117.28 132.72 11.63

Moderna information and performance

Moderna Address

200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 29 938 418 000 $

Market capitalization of the Moderna, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MRNA shares in the company outstanding by the market price of one share.

EBITDA: -2 166 000 128 $

EBITDA of Moderna is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -9.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.978
Quarterly Revenue Growth YOY: -0.456
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 32.47

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.54

Enterprise Value (EV) /Revenue

EV To EBITDA: 5.34

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 381284000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.